Earnings Winners & Losers: Orthopedics Firms, JNJ, NUVA, SNN, SYK, ZBH
Executive Summary
With earnings reporting season now in full swing, Medtech Insight highlights which companies have exceeded expectations and which ones continue to see their bottom-line sink. This edition throws the spotlight on some of the notable players in the orthopedics space.
You may also be interested in...
Medtronic Vet Christopher Barry Takes Helm At Nuvasive
About three years after becoming CEO of NuVasive, Gregory Lucier is ceding the role to Barry, who has led Medtronic's Surgical Innovations business, effective Nov. 5. Lucier will continue to serve as chairman of the board for the San Diego-based minimally-invasive spine surgery technology company.
Device Debut: DePuy Synthes Solidifies Knee Biz With Attune Revision's EMEA Launch
J&J/DePuy Synthes launched the Attune Revision Knee System to complement its Attune Primary Knee System in Europe, Middle East, and Africa. The launch was formally announced at the European Federation of the National Associations of Orthopedics and Traumatology (EFORT) Congress in Barcelona.
Exec Chat: Zimmer Biomet's EMEA Head On Facing The New Reality In Health Care
As Katarzyna Mazur-Hofsäss approaches her fifth anniversary as head of Zimmer Biomet's EMEA division, she chats with Medtech Insight about her concerns as medical device companies operating in Europe try to cope with the new regulatory environment and how the orthopedics giant is responding to new demands from health-care providers.